Jim Simons Frequency Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.35 - $0.72 $7,874 - $16,200	22,500 Added 5.5%	431,700 $160,000
Q2 2023 Aug 11, 2023	BUY	$0.33 - $0.48 $7,491 - $10,896	22,700 Added 5.87%	409,200 $142,000
Q1 2023 May 12, 2023	BUY	$0.44 - $5.47 $16,513 - $205,289	37,530 Added 10.75%	386,500 $194,000
Q4 2022 Feb 13, 2023	SELL	$1.88 - $3.85 $38,489 - $78,821	-20,473 Reduced 5.54%	348,970 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $363,218 - $634,389	-248,780 Reduced 40.24%	369,443 $661,000
Q2 2022 Aug 12, 2022	BUY	$1.03 - $2.03 $342,641 - $675,303	332,662 Added 116.49%	618,223 $927,000
Q1 2022 May 13, 2022	BUY	$1.7 - $5.72 $462,673 - $1.56 Million	272,161 Added 2031.05%	285,561 $605,000
Q4 2021 Feb 11, 2022	BUY	$4.95 - $7.11 $66,330 - $95,274	13,400 New	13,400 $69,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.